Catalyst Wire Dossier Catalyst Wire Dossier

CART-19 T cell Therapy

CD19-directed CAR-T cell · Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CART-19 T cell Therapy, covering 2023-11-29 to 2023-11-29. Get the full timeline:

Most recent: Clinical Trial Update: CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

See pricing